Home 3SBIOINC

3SBIOINC

In operation
Post-IPO Round
Biopharmaceutical Manufacturer
Basic
Enterprise Profile
LinkedIn

Basic Information

3SBio Group has always been committed to solving the clinical medication challenges faced by patients, continuously overcoming disease challenges, and improving patients' quality of life with high-quality medicines for the benefit of human health. As a leading company in China's rapidly developing biopharmaceutical industry, we possess a wealth of products under research, market-leading marketed products, and specialized expertise in manufacturing, marketing, and service. Since 1993, 3SBio Group has consistently regarded product quality as the lifeline of the enterprise. Currently, we have a rich pipeline of products under development, over 30 marketed products, 32 candidate products, including 22 national new drugs.
3SBio Group
Liaoning,China
more than 500 people
January 03, 1993
fengbowen@3sbio.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Biological Pharmaceutical Products
Technology
Biotechnology
Concept
Nephrology Department Dermatology Department Immune System Diseases Metabolic Diseases Therapeutic Products Breast Cancer Colorectal Cancer # Diabetes Mellitus
Application Scenarios
Innovative Drugs Monoclonal Antibody Bispecific Antibody